New insight of the mechanism of GBM neovascularization that GSCs could transdifferentiate into vascular endothelial cells was much impressive not only for one of the mechanisms of the resistance of anti- VEGF therapies but for the interaction of GSCs with vascular compartments took part in the microenvironment [10–12, 20]. This evidence concerns the gene VEGFA and glioblastoma.